Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Sep 30, 2023. (Total: 221577Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 11 (of 11 Records)

Query Trace: Neoplasms and meta-analysis and UGT1A1[original query]
The association between TA-repeat polymorphism in the promoter region of UGT1A1 and breast cancer risk: a meta-analysis.
Breast cancer research and treatment 2010 Aug 122 (3): 879-82.
Yao Lei, Qiu Li-Xin, Yu Lu, Yang Zhen, Yu Xia-Jia, Zhong Yang, Yu Lo
Impact of the UGT1A1*28 allele on response to irinotecan: a systematic review and meta-analysis.
Pharmacogenomics 2012 Jun 13 (8): 889-99.
Dias Mafalda M, McKinnon Ross A, Sorich Michael
Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians.
The pharmacogenomics journal 2014 Apr 14 (2): 120-9.
Liu X, Cheng D, Kuang Q, Liu G, Xu
Association between UGT1A1*28 polymorphisms and clinical outcomes of irinotecan-based chemotherapies in colorectal cancer: a meta-analysis in Caucasians.
PloS one 2013 8 (3): e58489.
Liu Xiang, Cheng Dangxiao, Kuang Qin, Liu Geoffrey, Xu W
UGT1A1*6 polymorphisms are correlated with irinotecan-induced toxicity: a system review and meta-analysis in Asians.
Cancer chemotherapy and pharmacology 2014 Mar 73 (3): 551-60.
Cheng Lei, Li Ming, Hu Jing, Ren Wei, Xie Li, Sun Zhan-Peng, Liu Bao-Rui, Xu Gen-Xing, Dong Xiao-Liang, Qian Xiao-Pi
UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis.
Cancer chemotherapy and pharmacology 2017 Jun .
Zhang Xue, Yin Jia-Fu, Zhang Jiao, Kong Shu-Jia, Zhang Hong-Yin, Chen Xue-M
UGT1A1 polymorphisms with irinotecan-induced toxicities and treatment outcome in Asians with Lung Cancer: a meta-analysis.
Cancer chemotherapy and pharmacology 2017 Jun 79 (6): 1109-1117.
Chen Xuewei, Liu Liping, Guo Zhihua, Liang Wenhua, He Jiaxi, Huang Liyan, Deng Qiuhua, Tang Hailing, Pan Hui, Guo Minzhang, Liu Yang, He Qihua, He Jianxi
Predictive Value of UGT1A1*28 Polymorphism In Irinotecan-based Chemotherapy.
Journal of Cancer 2017 8 (4): 691-703.
Liu Xing-Han, Lu Jun, Duan Wei, Dai Zhi-Ming, Wang Meng, Lin Shuai, Yang Peng-Tao, Tian Tian, Liu Kang, Zhu Yu-Yao, Zheng Yi, Sheng Qian-Wen, Dai Zhi-J
UGT1A1*6 and UGT1A1*28 polymorphisms are correlated with irinotecan-induced toxicity: A meta-analysis.
Asia-Pacific journal of clinical oncology 2018 Jun .
Yang Yuwei, Zhou MengMeng, Hu Mingjun, Cui Yanjie, Zhong Qi, Liang Ling, Huang F
Association of UGT1A1*6 polymorphism with irinotecan-based chemotherapy reaction in colorectal cancer patients: a systematic review and a meta-analysis.
Bioscience reports 2020 Sep .
Zhu Xiaoyun, Ma Ruchao, Ma Xin, Yang Ga
Association of UGT1A1*6, UGT1A1*28, or ABCC2 c.3972C>T genetic polymorphisms with irinotecan-induced toxicity in Asian cancer patients: Meta-analysis.
Clinical and translational science 2022 May .
Atasilp Chalirmporn, Biswas Mohitosh, Jinda Pimonpan, Nuntharadthanaphong Nutthan, Rachanakul Jiratha, Hongkaew Yaowaluck, Vanwong Natchaya, Saokaew Surasak, Sukasem Chonlaph
TOP